A transgenic mouse model of sickle cell disorder (original) (raw)
- Letter
- Published: 11 January 1990
- Peter Fraser1,
- Miguel A. Vidal1,
- Michael J. Hedges1 na1,
- David Ropers1 na1,
- Lucio Luzzatto1 na1 &
- …
- Frank Grosveld1
Nature volume 343, pages 183–185 (1990) Cite this article
- 738 Accesses
- 101 Citations
- 9 Altmetric
- Metrics details
Abstract
A SINGLE base-pair mutation (βs) in codon 6 of the human β-globin gene, causing a single amino-acid substitution, is the cause of sickle cell anaemia1. The mutant haemoglobin molecule, HbS, polymerizes when deoxygenated and causes deformation of the erythrocytes to a characteristic 'sickled' shape. Sickling of cells in small vessels causes painful crises and other life-threatening complications2,3. Although the molecular basis for sickle cell anaemia has been known for 30 years, no definitive treatment is available4. An animal model of sickle cell anaemia would not only allow a detailed analysis of the factors that initiate erythrocyte sickling in vivo and of the pathophysiology of the disease, but would also permit the development of novel approaches to the treatment of the disease. By using the dominant control region sequences from the human β-globin locus, together with human α and βS-globin genes, we have obtained three transgenic mice with HbS levels ranging from 10 to 80% of total haemoglobin in their red cells. As observed in homozygous and heterozygous Hbspatients, the erythrocytes of this mouse sickle readily on deoxygenation. Irreversibly sickled cells2,3, which are characteristic of sickle-cell patients homozygous for βs, are also observed in the peripheral blood of the mouse with high levels of HbS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 52 print issues and online access
$199.00 per year
only $3.83 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
- Ingram, V. A. Nature 178, 792 (1956).
Article ADS CAS Google Scholar - Serjeant G. R. Sickle Cell Disease (Oxford University Press, 1985).
Google Scholar - Schechter, A. N., Noguchi, C. T. & Rodgers, G. P. in The Molecular Basis of Blood Diseases (eds Stamatoyannopoulos, G., Nienhuis, A, W., Leder, P. & Majerus, P. W.) 179–218 (W. B. Saunders, Philadelphia, 1987).
Google Scholar - Luzzatto, L. & Goodfellow, P. Nature 337, 17–18 (1989).
Article ADS CAS Google Scholar - Grosveld, F., Blom van Assendelft, G., Greaves, D. R. & Kollias, G. Cell 51, 975–985 (1987).
Article CAS Google Scholar - Blom van Assendelft, G., Hanscombe, O., Grosveld, F. & Greaves, D. R. Cell 56, 969–977 (1989).
Article CAS Google Scholar - Talbot, D. et al. Nature 338, 352–355 (1989).
Article ADS CAS Google Scholar - Hanscombe, O. et al. Genes Dev. 3, 1572–1581 (1989).
Article CAS Google Scholar - Ryan, T. M. et al. Genes Dev. 3, 314–323 (1989).
Article CAS Google Scholar - Behringer, R. R. et al. Science 245, 971–973 (1989).
Article ADS CAS Google Scholar - Ryan, T. M., Behringer, R. R., Townes, T. M., Palmiter, R. D. & Brinster, R. L. Proc. natn. Acad. Sci. U.S.A. 86, 37–41 (1989).
Article ADS CAS Google Scholar - Collis, P., Antoniou, M. & Grosveld, F. EMBO J. (in the press).
- Daland, Q. A. & Castle, W. B. J. Lab. clin. Med. 33, 1082–1088 (1948).
CAS PubMed Google Scholar - Rhoda, M. D. et al. Biochim. biophys. Acta 953, 208–212, (1988).
Article Google Scholar - Bentles, J. F. & Milner, D. F. A. J. clin. Invest. 47, 1731–1741 1968).
Article Google Scholar - Noguchi, C. T. & Schecter, A. N. Blood 58, 1057–1068.
- Padilla, F., Bromberg, P. A. & Jensen, W. N. Blood 41, 653–660 (1978).
Google Scholar - van Ehrenstein, G. Acta physiol. Scand. 44, 80–91 (1948).
Article Google Scholar - van Patten, L. M. Blood 13, 789–794 (1958).
Google Scholar - Edington, G. M. & Lehmann, H. Br. Med. J. i, 1308–1311 (1955).
Article Google Scholar - Conley, C. L., Weatherall, D. J., Richardson, S. N., Shepard, M. K. & Charache, S. Blood 21, 261–281 (1963).
CAS PubMed Google Scholar - Talbot, J. F., Bird, A. C. & Sarjeant, G. R. Br. J. Ophthalmol. 67, 777–778 (1983).
Article CAS Google Scholar - Martinell, J., Whitney, J. B. III, Popp, R. A., Russell, L. B. & Anderson, W. F. Proc. natn. Acad. Sci. U.S.A. 78, 5056–5060 (1981).
Article ADS CAS Google Scholar - Skow, L. C. et al. Cell 34, 1043–1052.
Author information
Author notes
- Michael J. Hedges, David Ropers and Lucio Luzzatto: Haematology Department, Royal Postgraduate Medical School, Hammersmith Hospital, Du Cane Road, London W12 OHS, UK
Authors and Affiliations
- Laboratory of Gene Structure and Expression, National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 1AA, UK
David R. Greaves, Peter Fraser, Miguel A. Vidal, Michael J. Hedges, David Ropers, Lucio Luzzatto & Frank Grosveld
Authors
- David R. Greaves
- Peter Fraser
- Miguel A. Vidal
- Michael J. Hedges
- David Ropers
- Lucio Luzzatto
- Frank Grosveld
Rights and permissions
About this article
Cite this article
Greaves, D., Fraser, P., Vidal, M. et al. A transgenic mouse model of sickle cell disorder.Nature 343, 183–185 (1990). https://doi.org/10.1038/343183a0
- Received: 18 September 1989
- Accepted: 01 December 1989
- Issue date: 11 January 1990
- DOI: https://doi.org/10.1038/343183a0